bazedoxifene has been researched along with Disease Models, Animal in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (71.43) | 24.3611 |
| 2020's | 4 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, J; Reader, J; Roque, DM; Zhang, R | 1 |
| Guo, J; Huo, S; Li, C; Li, S; Lin, J; Lin, L; Liu, T; Luo, P; Lv, J; Ma, H; Shi, W; Tao, J; Yan, D; Zhai, M; Zhang, C | 1 |
| Guo, J; Huo, S; Li, C; Li, S; Lin, J; Lin, L; Liu, T; Luo, P; Lv, J; Ma, H; Shi, W; Wang, M; Wang, Y; Yan, D; Zhang, C; Zhao, C | 1 |
| Cho, JH; Chu, J; Chuang, LS; Gettler, K; Giri, M; Kenigsberg, E; Ko, HM; Kugathasan, S; Merad, M; Morrison, JK; Nayar, S; Walker, LA | 1 |
| Hashimoto, T; Kitazato, KT; Korai, M; Maekawa, H; Miyamoto, T; Nagahiro, S; Satomi, J; Tada, Y; Yagi, K | 1 |
| Bossen, J; Bruchhaus, I; Burkhardt, L; Fink, C; Heine, H; Mai, MM; Pfefferkorn, R; Roeder, T; Spohn, M; Steen, L; Uliczka, K | 1 |
| Komm, B; Krikun, G; Naqvi, H; Presti, T; Sakr, S; Taylor, HS | 1 |
| Chen, H; Chen, R; Dang, Q; Liu, Y; Lyu, H | 1 |
| Lovre, D; Mauvais-Jarvis, F; Xu, B | 1 |
| Arakawa, S; Kida, Y; Marumo, K; Nishizawa, T; Okabe, H; Saito, M; Seki, A | 1 |
| Andersson, A; Bernardi, AI; Carlsten, H; Islander, U; Nurkkala-Karlsson, M; Ohlsson, C; Stubelius, A | 1 |
| Cao, Y; Li, C; Lin, J; Wu, X; Xiao, H | 1 |
| Fischer, C; Komm, B; Kulak, J; Taylor, HS | 1 |
| Gordon, IO; Greene, GL; Krausz, TN; Lee, W; Lengyel, E; Leonhardt, P; Mitra, AK; Mui, KL; Penicka, CV; Romero, IL; Zhao, Y | 1 |
1 review(s) available for bazedoxifene and Disease Models, Animal
| Article | Year |
|---|---|
Effect of selective estrogen receptor modulators on metabolic homeostasis.
Topics: Animals; Breast; Breast Neoplasms; Diabetes Mellitus, Type 2; Disease Models, Animal; Estrogens; Female; Humans; Indoles; Metabolic Syndrome; Osteoporosis, Postmenopausal; Receptors, Estrogen; Uterus | 2016 |
13 other study(ies) available for bazedoxifene and Disease Models, Animal
| Article | Year |
|---|---|
Combined inhibition of IL‑6 and IL‑8 pathways suppresses ovarian cancer cell viability and migration and tumor growth.
Topics: Animals; Benzamides; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclobutanes; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Indoles; Interleukin-6; Interleukin-8; Mice; Ovarian Neoplasms; Selective Estrogen Receptor Modulators | 2022 |
Inhibition of Interleukin-6/glycoprotein 130 signalling by Bazedoxifene ameliorates cardiac remodelling in pressure overload mice.
Topics: Animals; Autophagy; Cytokine Receptor gp130; Disease Models, Animal; Gene Expression Regulation; Heart; Humans; Hypertension; Indoles; Interleukin-6; Mice; Rats; STAT3 Transcription Factor; Ventricular Remodeling | 2020 |
Bazedoxifene exhibits anti-inflammation and anti-atherosclerotic effects via inhibition of IL-6/IL-6R/STAT3 signaling.
Topics: Animals; Anti-Inflammatory Agents; Aorta; Atherosclerosis; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Interleukin-6; Male; Mice, Knockout, ApoE; Muscle, Smooth, Vascular; Phosphorylation; Plaque, Atherosclerotic; Rats; Receptors, Interleukin-6; Signal Transduction; STAT3 Transcription Factor | 2021 |
A myeloid-stromal niche and gp130 rescue in NOD2-driven Crohn's disease.
Topics: Alleles; Animals; Collagen; Crohn Disease; Cytokine Receptor gp130; Disease Models, Animal; Female; Fibroblasts; Humans; Ileitis; Indoles; Interleukin-11; Lipopolysaccharide Receptors; Macrophages; Male; Myeloid Cells; Nod2 Signaling Adaptor Protein; Receptor, Platelet-Derived Growth Factor alpha; STAT3 Transcription Factor; Stromal Cells; WT1 Proteins; Zebrafish; Zebrafish Proteins | 2021 |
Bazedoxifene, a selective estrogen receptor modulator, reduces cerebral aneurysm rupture in Ovariectomized rats.
Topics: Animals; Blood Pressure; Cerebral Arteries; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Gene Expression Regulation; Hypertension; Indoles; Intracranial Aneurysm; Matrix Metalloproteinase 2; Ovariectomy; Rats; Rats, Sprague-Dawley; RNA, Messenger; Salts; Selective Estrogen Receptor Modulators; Tissue Inhibitor of Metalloproteinase-2 | 2017 |
An EGFR-Induced
Topics: Animals; Animals, Genetically Modified; Carcinoma, Non-Small-Cell Lung; Disease Models, Animal; Drosophila melanogaster; Drosophila Proteins; Drug Synergism; ErbB Receptors; Gene Expression Profiling; Humans; Indoles; Lung Neoplasms; Mutation; Protein Kinase Inhibitors; Trachea | 2019 |
Treatment with bazedoxifene and conjugated estrogens results in regression of endometriosis in a murine model.
Topics: Animals; Cell Proliferation; Disease Models, Animal; Endometriosis; Estrogen Receptor alpha; Estrogens, Conjugated (USP); Female; Humans; Indoles; Mice, Inbred Strains; Organ Size; Ovarian Follicle; Random Allocation; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Treatment Outcome | 2014 |
[Effect of bazedoxifene on endometriosis in a rat model].
Topics: Animals; Disease Models, Animal; Endometriosis; Endometrium; Female; Humans; Immunohistochemistry; Indoles; Proliferating Cell Nuclear Antigen; Rats; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Uterus | 2015 |
Effects of 18-month treatment with bazedoxifene on enzymatic immature and mature cross-links and non-enzymatic advanced glycation end products, mineralization, and trabecular microarchitecture of vertebra in ovariectomized monkeys.
Topics: Animals; Arginine; Bone Density; Bone Density Conservation Agents; Collagen; Cross-Linking Reagents; Disease Models, Animal; Female; Glycation End Products, Advanced; Humans; Indoles; Lumbar Vertebrae; Lysine; Macaca fascicularis; Osteoporosis, Postmenopausal; Ovariectomy; Selective Estrogen Receptor Modulators; X-Ray Microtomography | 2015 |
Selective oestrogen receptor modulators lasofoxifene and bazedoxifene inhibit joint inflammation and osteoporosis in ovariectomised mice with collagen-induced arthritis.
Topics: Animals; Area Under Curve; Arthritis, Experimental; Biomarkers; Collagen; Disease Models, Animal; Female; Flow Cytometry; Humans; Indoles; Interleukin-6; Mice; Mice, Inbred DBA; Osteoarthritis; Osteoporosis, Postmenopausal; Ovariectomy; Pyrrolidines; Random Allocation; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes; Treatment Outcome | 2016 |
Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Density Conservation Agents; Cell Line, Tumor; Cell Survival; Cytokine Receptor gp130; Cytokines; Disease Models, Animal; Female; Humans; Indoles; Mice; Models, Molecular; Molecular Conformation; Pancreatic Neoplasms; Phosphorylation; Protein Binding; Selective Estrogen Receptor Modulators; Signal Transduction; STAT Transcription Factors; Xenograft Model Antitumor Assays | 2016 |
Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model.
Topics: Animals; Caspase 3; Disease Models, Animal; Endometriosis; Female; Indoles; Mice; Proliferating Cell Nuclear Antigen; Receptors, Estrogen; Selective Estrogen Receptor Modulators | 2011 |
The effects of 17β-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesis.
Topics: Animals; Cell Growth Processes; Cell Line, Tumor; Cell Transformation, Neoplastic; Disease Models, Animal; Drug Interactions; Estradiol; Estrogen Antagonists; Female; Genetic Predisposition to Disease; Indoles; Mice; Mice, Transgenic; Neoplasm Invasiveness; Ovarian Neoplasms; Ovary; Selective Estrogen Receptor Modulators | 2012 |